• December 6, 2020
  • EFSA

EFSA | Consultation on the draft on biological plausibility of non-monotonic dose responses and their impact on the risk assessment


Your substances

None


EFSA's Scientific Committee has launched an open consultation on its draft EFSA Scientific Committee Opinion on biological plausibility of non-monotonic dose responses and their impact on the risk assessment. This document assesses the biological relevance of the apparent non-monotonic dose-responses identified in the external report produced under GP/EFSA/SCER/2014/01, focusing on the in vivo datasets fulfilling most of the checkpoints of the visual/statistics-based analysis. 

CONTINUE READING ON www.efsa.europa.eu

                   

Related News

Loading...